Medical Cannabis Manufacturing

Valcon Medical partners with companies operating in regulated markets. We offer complete white label solutions, bulk extracts, and contract processing of partner-supplied plant material. In addition, we provide contract manufacturing services for specialized development and production projects.

Valcon Medical combines advanced extraction technology with a commitment to innovation, delivering high-quality medical cannabis products consistently and at scale.

Our primary manufacturing technology is CO₂ extraction, while we continue to expand into advanced processing and extraction technologies to broaden our capabilities and service offering.

A key focus of our manufacturing approach is the preservation of the plant’s natural characteristics. Through carefully controlled extraction and processing methods, we strive to retain the unique cannabinoid and terpene profiles of each cultivar, enabling products that closely reflect the properties of the original plant material.

This strain-specific approach supports product differentiation and provides our partners with a broad range of formulation possibilities.

Valcon Medical operates in compliance with EU-GMP requirements and is licensed by the Danish Medicines Agency under the Danish legislation governing medical cannabis.

Our products and raw materials comply with applicable requirements of the German Pharmacopoeia (DAB) and the European Pharmacopoeia (Ph. Eur.) for their intended application.

Download our current regulatory documentation below:

Authorisation to manufacture cannabis bulk and cannabis primary products
Authorisation no. 105294

Authorisation to manufacture cannabis intermediate products
Authorisation no. 104934

Authorisation of activities with euphoriant substances
Authorisation no. 104059